Mailing Abortion Pills Temporarily Blocked By Fifth Circuit (2)

A federal appeals court temporarily blocked the mailing of mifepristone, narrowing women’s access to the abortion drug.

The US Court of Appeals for the Fifth Circuit on Friday granted Louisiana’s request to temporarily pause Food and Drug Administration decisions that allowed mifepristone to be mailed into the state despite its abortion ban. The order effectively pauses the FDA’s 2023 Risk Evaluation and Mitigation Strategy (REMS), which removed a requirement that mifepristone be dispensed in-person.

The FDA’s decision “injures Louisiana by undermining its laws protecting unborn human life and also by causing it to spend Medicaid funds on emergency care for ...